Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-10-23

FDA Approved: RISEDRONATE SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Risendronate Sodium from Sun Pharmaceutical Industries to update labeling for the generic osteoporosis drug rise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISEDRONATE SODIUM (RISEDRONATE SODIUM)

Snippet

SUPPL AP for RISEDRONATE SODIUM (RISEDRONATE SODIUM)